Ravina Kullar
Impact in
-
- Antibiotic Use and Resistance
- Clinical Biochemistry top 0.2%
- Bacterial Identification and Susceptibility Testing
Papers in
-
- Antimicrobial Resistance in Staphylococcus 24
- Clostridium difficile and Clostridium perfringens research 6
- Epidemiology 29
- Infective Endocarditis Diagnosis and Management 9
- Liver Disease Diagnosis and Treatment 6
- Co-authors
- Michael J. Rybak (16 shared papers)Susan L. Davis (10 shared papers)Donald P. Levine (7 shared papers)George Sakoulas (14 shared papers)Debra A. Goff (10 shared papers)Ellie J. C. Goldstein (9 shared papers)Keith S. Kaye (5 shared papers)Lucas Schulz (4 shared papers)
- Journals
- Clinical Infectious Diseases (12 papers)Open Forum Infectious Diseases (7 papers)Antimicrobial Agents and Chemotherapy (6 papers)Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (5 papers)Infectious Diseases and Therapy (4 papers)
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Ravina Kullar
71 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 141
- Applied Microbiology and Biotechnology 459
- Clinical Biochemistry 990
- Infectious Diseases 1.6k
- Molecular Medicine 298
- Pharmacology 715
Countries citing papers authored by Ravina Kullar
This map shows the geographic impact of Ravina Kullar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ravina Kullar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ravina Kullar more than expected).
Fields of papers citing papers by Ravina Kullar
This network shows the impact of papers produced by Ravina Kullar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ravina Kullar. The network helps show where Ravina Kullar may publish in the future.
Co-authors
The 25 scholars most cited alongside Ravina Kullar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 356 | |
| 2 | 2016 | 162 | |
| 3 | 2014 | 139 | |
| 4 | 2019 | 138 | |
| 5 | 2013 | 128 | |
| 6 | 2014 | 118 | |
| 7 | 2011 | 110 | |
| 8 | 2011 | 91 | |
| 9 | 2020 | 84 | |
| 10 | 2013 | 80 | |
| 11 | 2013 | 76 | |
| 12 | 2012 | 75 | |
| 13 | 2023 | 70 | |
| 14 | 2013 | 69 | |
| 15 | 2015 | 68 | |
| 16 | 2019 | 65 | |
| 17 | 2015 | 56 | |
| 18 | 2017 | 50 | |
| 19 | 2011 | 47 | |
| 20 | 2014 | 43 |
About Ravina Kullar
Ravina Kullar is a scholar working on Infectious Diseases, Epidemiology, Clinical Biochemistry, Applied Microbiology and Biotechnology and Pharmacology, having authored 71 papers that have together received 2.8k indexed citations. Recurring topics across this work include Bacterial Identification and Susceptibility Testing (25 papers), Antimicrobial Resistance in Staphylococcus (24 papers), Antibiotic Use and Resistance (16 papers), Infective Endocarditis Diagnosis and Management (9 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers), Clostridium difficile and Clostridium perfringens research (6 papers), Hepatitis C virus research (6 papers) and Liver Disease Diagnosis and Treatment (6 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (459 citations), Clinical Biochemistry (990 citations), Infectious Diseases (1.6k citations), Molecular Medicine (298 citations) and Pharmacology (715 citations). Ravina Kullar has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Michael J. Rybak, Susan L. Davis, Donald P. Levine, George Sakoulas, Debra A. Goff, Ellie J. C. Goldstein, Keith S. Kaye, Lucas Schulz, Warren E. Rose and Jing Zhao. Their work appears in journals such as Clinical Infectious Diseases, Open Forum Infectious Diseases, Antimicrobial Agents and Chemotherapy, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy and Infectious Diseases and Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.